Onconova Therapeutics Inc. (ONTX) is priced at $7.13 after the most recent trading session. At the very opening of the session, the stock price was $6.69 and reached a high price of $8.00, prior to closing the session it reached the value of $7.46. The stock touched a low price of $6.5601.
Recently in News on June 10, 2021, Onconova Therapeutics Announces Participation in A.G.P.’s Upcoming Virtual Summer Healthcare Symposium. Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that members of the Company’s management team will participate in A.G.P.’s Virtual Summer Healthcare Symposium on Thursday, June 17, 2021. You can read further details here
Onconova Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $28.95 on 02/18/21, with the lowest value was $6.17 for the same time period, recorded on 06/04/21.
Onconova Therapeutics Inc. (ONTX) full year performance was -0.19%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Onconova Therapeutics Inc. shares are logging -75.37% during the 52-week period from high price, and 150.04% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.85 and $28.95.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 829810 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Onconova Therapeutics Inc. (ONTX) recorded performance in the market was 6.77%, having the revenues showcasing -55.20% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 115.18M, as it employees total of 11 workers.
Onconova Therapeutics Inc. (ONTX) in the eye of market guru’s
During the last month, 2 analysts gave the Onconova Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 12.87, with a change in the price was noted -5.19. In a similar fashion, Onconova Therapeutics Inc. posted a movement of -41.61% for the period of last 100 days, recording 2,507,670 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ONTX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Onconova Therapeutics Inc. (ONTX): Stocks Technical analysis and Trends
Raw Stochastic average of Onconova Therapeutics Inc. in the period of last 50 days is set at 10.75%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 10.75%. In the last 20 days, the company’s Stochastic %K was 9.36% and its Stochastic %D was recorded 7.19%.
If we look into the earlier routines of Onconova Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 6.77%. Additionally, trading for the stock in the period of the last six months notably improved by 58.29%, alongside a downfall of -0.19% for the period of the last 12 months. The shares increased approximately by 11.51% in the 7-day charts and went up by -8.75% in the period of the last 30 days. Common stock shares were lifted by -55.20% during last recorded quarter.